U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C12H21N.ClH
Molecular Weight 215.763
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of RIMANTADINE HYDROCHLORIDE

SMILES

Cl.CC(N)C12CC3CC(CC(C3)C1)C2

InChI

InChIKey=OZBDFBJXRJWNAV-UHFFFAOYSA-N
InChI=1S/C12H21N.ClH/c1-8(13)12-5-9-2-10(6-12)4-11(3-9)7-12;/h8-11H,2-7,13H2,1H3;1H

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
RIMANTADINE HYDROCHLORIDE
MART.   MI   ORANGE BOOK   USAN   USP   USP-RS   VANDF   WHO-DD  
USAN  
Official Name English
Rimantadine hydrochloride [WHO-DD]
Common Name English
TRICYCLO(3.3.1.1(SUP 3,7))-DECANE-1-METHANAMINE, .ALPHA.-METHYL-, HYDROCHLORIDE
Common Name English
RIMANTADINE HCL
Common Name English
RIMANTADINE HYDROCHLORIDE [ORANGE BOOK]
Common Name English
RIMANTADINE HYDROCHLORIDE [MART.]
Common Name English
RIMANTADINE HYDROCHLORIDE [USP MONOGRAPH]
Common Name English
FLUMADINE
Brand Name English
RIMANTADINE HYDROCHLORIDE [USP-RS]
Common Name English
NSC-206764
Code English
EXP-126
Code English
α-Methyl-1-adamantanemethylamine hydrochloride
Systematic Name English
RIMANTADINE HYDROCHLORIDE [VANDF]
Common Name English
EXP 126
Code English
RIMANTADINE HYDROCHLORIDE [USAN]
Common Name English
RIMANTADINE HYDROCHLORIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C281
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
Code System Code Type Description
SMS_ID
100000078643
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
DRUG BANK
DBSALT000833
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
RS_ITEM_NUM
1604508
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
DAILYMED
JEI07OOS8Y
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
ChEMBL
CHEMBL959
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
MERCK INDEX
m9621
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY Merck Index
CAS
1501-84-4
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
FDA UNII
JEI07OOS8Y
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
NSC
206764
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
NCI_THESAURUS
C61928
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
PUBCHEM
15165
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
EVMPD
SUB15141MIG
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
EPA CompTox
DTXSID1047813
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY
RXCUI
82093
Created by admin on Fri Dec 15 14:59:07 UTC 2023 , Edited by admin on Fri Dec 15 14:59:07 UTC 2023
PRIMARY RxNorm
ACTIVE MOIETY
Structure of RIMANTADINE
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966